Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa.
about
Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief reviewUse of lectin-functionalized particles for oral immunotherapyPlant extract synthesized PLA nanoparticles for controlled and sustained release of quercetin: a green approachDesigner nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier.Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancerDevelopment of functional biomaterials with micro- and nanoscale technologies for tissue engineering and drug delivery applications.Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colon.Nanomedicine in GIEffect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.Development of a pH-responsive particulate drug delivery vehicle for localized biologic therapy in inflammatory bowel diseaseEnhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticlesOral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers.Polymeric nanoparticle drug delivery technologies for oral delivery applications.Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers.Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.Physical approaches to biomaterial design.Nanoparticle Formulation Increases Oral Bioavailability of Poorly Soluble Drugs: Approaches Experimental Evidences and TheoryIntestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats.Colonic treatments and targets: issues and opportunities.Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Effects of the Microparticle Shape on Cellular Uptake.ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling.Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activityNanoscale particle therapies for wounds and ulcers.Nanoparticulate drug delivery systems for cancer chemotherapy.Microfabricated particulate drug-delivery systems.Models for oral uptake of nanoparticles in consumer products.Approaching the asymptote: obstacles and opportunities for nanomedicine in cardiovascular disease.Molecular buckets: cyclodextrins for oral cancer therapy.The role of particle geometry and mechanics in the biological domain.New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities.Nanotechnology in the treatment of inflammatory bowel diseases.Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices.Safety and toxicity concerns of orally delivered nanoparticles as drug carriers.Differences in physicochemical properties to consider in the design, evaluation and choice between microparticles and nanoparticles for drug delivery.
P2860
Q26743907-D50E21FA-0A38-4104-9204-7EE459CC7237Q26849550-777ABA03-959D-44CF-A10E-E93265B9F170Q28481474-FE8D50CE-71C3-4063-9FF2-97F6E182737AQ30476027-CD7950CF-6361-48C2-8DE3-017318D70B24Q31161857-8B3E6785-C442-429C-A29D-4841218CA159Q33689872-6B0C8106-F32C-4212-B773-8D2958B07026Q33984297-2777728B-4372-44C8-88DA-6C7B6F66F22DQ34349709-ED1269CD-A2B4-4A61-A891-E8BA8C85F3E3Q34354205-C7953C47-87F8-454C-B8FC-A5F373262332Q34719056-8E8C87F5-9731-4CBC-A08D-6439D64B7223Q34749181-34F9094A-2BF6-4E02-891F-81BB64D8E486Q35124399-19B1E7C3-7787-44D1-BDC2-842A8EE0D9D7Q35228674-72E1477D-92A4-4D0A-9E25-49AF68E5F3C4Q35871764-781845CD-A71E-452C-BB16-8D79BB534B24Q35877982-DDD605AD-3092-4B87-8087-5916BE2ABE8FQ36808308-BCEEE33F-E3D3-4AAB-AB6B-54D4D6BD86EFQ36838213-F6B96C7A-DEDE-475B-B2BB-01EF53CDD3D0Q37153923-286940AE-9C67-4E90-9344-13D401D9BAA5Q37284600-FCB84C7A-EE65-4DF7-8E9C-616F4D622D01Q37354840-A8A7E5BF-0644-4CFE-B76D-FF41A60B548CQ37401107-76A7C017-B7B3-4310-BE4E-01431939513FQ37413157-7567DDE9-E364-498F-B2D2-FC7218E09BA3Q37530912-DD997B52-54B2-4A9D-808C-E8A7BA9B472EQ37638947-4EB0AA3E-8199-43A2-8E67-CD4FA58C577AQ37650579-C2437A7D-C76D-43AC-876F-DDDF65EBA9D4Q37663040-8FC16CC9-6192-41FF-8154-49AC6BBE665AQ37690479-841A0CC5-FB0E-444A-AEAD-E5F3610B1FF3Q37714557-76751497-1E2F-4B05-A28C-CCBB6FB6F6C2Q37763155-FEBACBE3-0229-43A0-B3F4-8B2B283A25CBQ37799616-98BE64F2-0A0F-4F1F-88CF-6C5E2F66F20FQ37955127-B8BCE5DD-F87E-4843-ACA8-B397DD291A8FQ37961539-E79416BA-64CA-4ECF-B083-6DCED98CFE77Q38006425-B25308AF-4F8A-45A6-870E-3303933FE8BCQ38029632-D06C8686-2A86-4601-BFDE-3C97F57B117DQ38062890-A22F73D1-CE3F-4FD4-9887-594CC5770C54Q38110619-A928A4A1-9D7B-4280-9D01-681636F3447DQ38200842-96F86981-270F-4566-AC3E-38EB1BF2E706Q38239571-0AE9F641-7A73-4347-80D2-813A0AD940F8Q38286203-640F8F0E-6B75-4593-9258-C5D4D2126611Q38291341-5C2C76FE-8C66-4065-8F6B-C2C7507062AB
P2860
Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Size-dependent bioadhesion of ...... o the inflamed colonic mucosa.
@ast
Size-dependent bioadhesion of ...... o the inflamed colonic mucosa.
@en
type
label
Size-dependent bioadhesion of ...... o the inflamed colonic mucosa.
@ast
Size-dependent bioadhesion of ...... o the inflamed colonic mucosa.
@en
prefLabel
Size-dependent bioadhesion of ...... o the inflamed colonic mucosa.
@ast
Size-dependent bioadhesion of ...... o the inflamed colonic mucosa.
@en
P356
P1476
Size-dependent bioadhesion of ...... to the inflamed colonic mucosa
@en
P2093
A Lamprecht
P304
P356
10.1023/A:1011032328064
P577
2001-06-01T00:00:00Z